After elbowing its way into the thick of the pop-culture conversation, women's sports are now commanding a volume of ...

The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...

Ads during women's sports programs were 40% more impactful than the average primetime advertisement, according to EDO.

Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2024 investor letter. A ...

AbbVie hopes for continued strong sales for Rinvoq and fellow anti-inflammatory drug Skyrizi following the loss of patent protection for its former blockbuster drug Humira and the rise of ...

In 2019, following the steps of previously established social media giants such as Facebook, Twitter, and Instagram, TikTok launched an advertising platform called TikTok Ads. Having such a big, ...

While its blockbuster Humira faces biosimilar competition, the company's newer drugs Rinvoq and Skyrizi are delivering impressive results. Management's combined sales forecast for these ...

A lawyer at advertising conglomerate Interpublic Group fielded a phone call in December from a lawyer at X. The message was clear, according to several people with knowledge of the conversation ...

Independent tests conducted by in-house Cybernews experts are the foundation of our comprehensive ad blockers’ reviews. We combine in-house and external tests to gather empirical evidence and assess ...